Protocolisation, use and development of anti-cancer drugs in the context of T2A (case-mix based payment system) set-up

Drugs used in oncology represent more than half of the innovative and costly drugs which are not covered by a Group Homogène de Soins (DRG type classification) within the context of the case-mix based payment system (termed T2A). For these drugs, good practice reference guidelines have been drawn up...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Therapie 2006-07, Vol.61 (4), p.305-312
Hauptverfasser:	Mathieu-Boué, Anne, Demolis, Pierre, Bergmann, Jean-François
Format:	Artikel
Sprache:	eng ; fre
Schlagworte:	Antineoplastic Agents - economics Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - economics Antineoplastic Combined Chemotherapy Protocols - therapeutic use Diagnosis-Related Groups Drug Prescriptions Guidelines as Topic Humans Neoplasms - drug therapy Neoplasms - economics Physicians
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!